Body composition and disease severity in idiopathic pulmonary fibrosis

Body composition and disease severity in idiopathic pulmonary fibrosis - Body composition in IPF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005346

Enrollment

Registered

2011-03-31

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic pulmonary fibrosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with IPF diagnosed with ATS/ERS/JRS/ALAT guideline 2011 2) Without any infection and acute exacerbation within 3 mo 3) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with uncontrolled comorbidities 2) Patients who cannot undergo pulmonary function test and/or 6-min walk test

Design outcomes

Primary

Measure	Time frame
1) Body composition 2) Pulmonary function test 3) Arterial blood gas analysis 4) 6-min walk test	—

Secondary

Measure	Time frame
1) Daily dyspnea (BDI, modified MRC) 2) Health-related quality of life (SGRQ) 3) Depression (HADS) 4) Mental status (MMSE)	—

Countries

Japan

Contacts

Public ContactOsamu Nishiyama

Kinki University School of Medicine Departement of Respiratory Medicine and Allergology

nishi-o@med.kindai.ac.jp072-366-0221

Outcome results